Time to initiation of anti-tuberculosis treatment

被引:68
|
作者
Pirkis, JE
Speed, BR
Yung, AP
Dunt, DR
MacIntyre, CR
机构
[1] FAIRFIELD HOSP,FAIRFIELD,VIC 3078,AUSTRALIA
[2] AUSTRALIAN NATL UNIV,NATL CTR EPIDEMIOL & POPULAT HLTH,CANBERRA,ACT 2601,AUSTRALIA
[3] UNIV WESTERN AUSTRALIA,DEPT PUBL HLTH,NEDLANDS,WA 6009,AUSTRALIA
来源
TUBERCLE AND LUNG DISEASE | 1996年 / 77卷 / 05期
关键词
D O I
10.1016/S0962-8479(96)90111-2
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Objective: To examine delay in initiation of treatment for tuberculosis (TB). Design: Delay in the initiation of treatment for 142 notified TB patients was examined by a retrospective record review. Particular attention was given to the periods between (1) onset of symptoms and initiation of treatment, and (2) determination of sputum positivity and initiation of treatment. An expert panel nominated 30 days and 3 days as 'acceptable' periods for (1) and (2), respectively. Results: Only 31% of patients commenced treatment within 30 days of onset of symptoms. This was so for both sputum smear-positive and negative cases, and was not significantly related to the site of infection, referral source, age, gender or ethnicity of the patient. Of patients with smear-positive pulmonary TB, 86% received treatment within 3 days of this result being demonstrated. Those with a delay of greater than 3 days were all investigated by private doctors through private laboratories. Conclusion: There are appreciable delays in initiation of treatment for TB. Measures to combat these unacceptable delays are discussed.
引用
收藏
页码:401 / 406
页数:6
相关论文
共 50 条
  • [41] Non-Adherence of New Pulmonary Tuberculosis Patients to Anti-Tuberculosis Treatment
    Kulkarni, P. Y.
    Akarte, S., V
    Mankeshwar, R. M.
    Bhawalkar, J. S.
    Banerjee, A.
    Kulkarni, A. D.
    ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH, 2013, 3 (01) : 67 - 74
  • [42] Gut Mycobiota Dysbiosis in Pulmonary Tuberculosis Patients Undergoing Anti-Tuberculosis Treatment
    Cao, Demin
    Liu, Weihua
    Lyu, Na
    Li, Boxing
    Song, Weibo
    Yang, Yanxiao
    Zhu, Jianliang
    Zhang, Zhiguo
    Zhu, Baoli
    MICROBIOLOGY SPECTRUM, 2021, 9 (03):
  • [43] Comparison of time to positive and colony counting in an early bactericidal activity study of anti-tuberculosis treatment
    Bark, C. M.
    Gitta, P.
    Ogwang, S.
    Nsereko, M.
    Thiel, B. A.
    Boom, W. H.
    Eisenach, K. D.
    Joloba, M. L.
    Johnson, J. L.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (11) : 1448 - 1451
  • [44] Gut Microbiome in Probable Intestinal Tuberculosis and Changes following Anti-Tuberculosis Treatment
    Yoon, Hyuk
    Park, Young Soo
    Shin, Cheol Min
    Kim, Nayoung
    Lee, Dong Ho
    YONSEI MEDICAL JOURNAL, 2022, 63 (01) : 34 - 41
  • [45] TREATMENT OF PULMONARY TUBERCULOSIS WITH ACTH AND CORTISONE IN ADDITION TO SPECIFIC ANTI-TUBERCULOSIS THERAPY
    JESIOTR, M
    DISEASES OF THE CHEST, 1958, 33 (02): : 180 - 192
  • [46] Pituitary tuberculosis and hypothalamic obesity can be reversed by prolonged anti-tuberculosis treatment
    Rochtus, Anne
    Lagae, Lieven
    Vermeulen, Francois
    de Zegher, Francis
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 370 - 370
  • [47] Anti-tuberculosis work in Italy
    不详
    LANCET, 1934, 1 : 664 - 665
  • [48] PSYCHOSIS AND ANTI-TUBERCULOSIS THERAPY
    UPADHYAYA, MP
    CHATURVEDI, SK
    LANCET, 1989, 2 (8665): : 735 - 736
  • [49] INTERNATIONAL ANTI-TUBERCULOSIS CENTRES
    不详
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1951, 65 (05) : 484 - 484
  • [50] Anti-tuberculosis work in Wales
    不详
    LANCET, 1939, 1 : 648 - 649